StocksUpdated×31•Originally published 7 May 2026•Updated 9 May 2026•

1 min read

US Biotech and Mid-Cap Firms Report Q1 2026 Earnings Results

Key Facts

1ADMA Biologics released its Q1 2026 earnings call transcript.

2ACADIA Pharmaceuticals announced its Q1 2026 financial results.

3Accuray Incorporated published its fiscal Q3 2026 earnings results.

The Q1 2026 earnings cycle has expanded as CRA International, Inc. (CRAI) conducted its earnings call to report quarterly financial results. The medical and biotech sectors gained momentum with financial data from Outset Medical (OM), Zymeworks (ZYME), and Ascendis Pharma A/S (ASND), alongside the latest Q1 earnings report from ALX Oncology Holdings Inc. (ALXO). Industrial player Alta Equipment Group Inc. (ALTG) held its Q1 earnings call, while Brazilian education firm Cogna Educação S.A. (COGNY) released its quarterly results. Paylocity (PCTY) also reported its Q3 figures alongside updates from Gilead Sciences (GILD) and SoundHound AI (SOUN). Market participants are analyzing these diverse disclosures to assess operational resilience across the US and international landscapes.

26 days ago

Version History

9 additional sources confirmed this story

Version 3126 days ago

What changed: Added Q1 2026 earnings data for ALX Oncology Holdings Inc. (ALXO) to the biotech sector coverage.

Version 3026 days ago

What changed: The report was updated to include the Q1 2026 financial performance and earnings call transcript for CRA International, Inc. (CRAI).

Version 2926 days ago

What changed: Added earnings reports from the industrial equipment, medical technology, and education sectors involving ALTG, OM, and COGNY.

Version 2826 days ago

What changed: The story was updated to include the Q1 2026 earnings results and conference call details for Ascendis Pharma A/S (ASND).

Version 2726 days ago

What changed: Added earnings updates for Zymeworks, Paylocity, and E.W. Scripps, expanding the coverage to media and payroll service sectors.

Version 2626 days ago

What changed: Added Q1 2026 earnings reports for Applied Optoelectronics (AAOI) and Magazine Luiza S.A. (MGLUY) to the existing earnings cycle coverage.

Version 2526 days ago

What changed: The story was updated to include earnings data for GSBD, LEGH, and JOUT, expanding coverage of the financial, housing, and consumer sectors.

Version 2426 days ago

What changed: Added Q1 2026 earnings reports for DTI and HRTG to the existing mid-cap earnings coverage.

Version 2326 days ago

What changed: Added five new mid-cap companies (ICFI, DIBS, EVCM, MBI, ULBI) to the Q1 2026 earnings coverage.

Version 2226 days ago

What changed: Added Q1 2026 earnings call details for Creative Media & Community Trust Corporation (CMCT).

Version 2126 days ago

What changed: Added Q1 2026 earnings reports for TechTarget (TTGT) and PAR Technology (PAR) to the existing mid-cap earnings coverage.

Version 2026 days ago

What changed: Added Q1 2026 earnings information for Cipher Pharmaceuticals (CPH:CA) to the existing coverage.

Version 1926 days ago

What changed: Updated the story to include Forward Air's earnings miss and divestiture plan, Griffon Corporation's earnings beat, and new reports from the tech and consumer sectors.

Version 1827 days ago

What changed: Added earnings reports for SRTS, ABSI, FLUX, and RCAT to the existing biotech and mid-cap earnings coverage.

Version 1727 days ago

What changed: The story was updated to include additional earnings reports from CWEN, NNDM, SRI, GSIT, and WEST.

Version 1627 days ago

What changed: Updated the story to include Q1 2026 earnings results for INmune Bio Inc. (INMB), Miller Industries, Inc. (MLR), and FIGS, Inc. (FIGS).

Version 1527 days ago

What changed: Added Q1 2026 earnings data for Pacific Biosciences of California (PACB) to the existing biotech sector coverage.

Version 1427 days ago

What changed: The story was updated to include Q1 earnings results from Gilead Sciences and 10x Genomics within the biotech sector.

Version 1327 days ago

What changed: Added Q1 2026 earnings reports for Arcturus Therapeutics (ARCT) and Palvella Therapeutics (PVLA).

Version 1227 days ago

What changed: Updated the story to include Q1 earnings reports for Akamai, Monster Beverage, NuScale Power, Diodes, Maximus, and Ormat.

Version 1127 days ago

What changed: Added Q1 2026 earnings data for Vericel Corporation (VCEL) to the existing biotech and mid-cap reporting cluster.

Version 1027 days ago

What changed: The story was updated to include earnings reports from the technology and AI sectors, specifically adding MCHP, SOUN, and GEN.

Version 927 days ago

What changed: The story has been updated to include a large batch of new earnings reports from the technology, energy, healthcare, and consumer discretionary sectors, adding 14 new companies to the coverage.

Version 827 days ago

What changed: Expanded coverage to include earnings results from Albemarle, Viatris, US Foods, and Fidelity National, along with several industrial and specialized firms.

Version 727 days ago

What changed: Updated the story to include earnings results from McDonald's and additional firms in the fintech, energy, and biopharma sectors.

Version 627 days ago

What changed: The story was updated to include a new batch of mid-cap and small-cap earnings reports across the finance, shipping, and healthcare sectors.

Version 527 days ago

What changed: Allegro MicroSystems (ALGM) was added to the earnings cycle, reporting a beat on earnings estimates for Q4 2026.

Version 428 days ago

What changed: Added DoubleVerify Holdings, Inc. (DV) to the list of mid-cap companies reporting Q1 2026 earnings.

Version 328 days ago

What changed: The story was updated to include Q1 earnings results for Alcon Inc. (ALC) and Sinch AB (CLCMF).

Version 228 days ago

What changed: Added Ibotta, electroCore, and Sunrun to the list of mid-cap companies reporting Q1 2026 earnings results.

Version 128 days ago

What changed: Added earnings reports for Sight Sciences (SGHT), Vanda Pharmaceuticals (VNDA), and Chunghwa Telecom (CHT) to the existing biotech and mid-cap earnings cluster.